Evidence map›Paper›PMID 30201705›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Universal method for robust detection of circadian state from gene expression.

Rosemary Braun, William L Kath, Marta Iwanaszko, Elzbieta Kula-Eversole, Sabra M Abbott, Kathryn J Reid, Phyllis C Zee, Ravi Allada

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. A gradual and sustainable approach to diagnosing sleep and circadian disturbances in dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. HairTime: A noninvasive assay for estimating circadian phase from a single hair sample.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Research priorities to improve classification of sleep-wake disorders.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Rosemary BraunBiostatistics Division, Department of Preventive Medicine, Northwestern University, Chicago, IL 60611; rbraun@northwestern.edu.ORCID 0000-0001-9668-9866
William L KathDepartment of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, IL 60208.
Marta IwanaszkoBiostatistics Division, Department of Preventive Medicine, Northwestern University, Chicago, IL 60611.
Elzbieta Kula-EversoleDepartment of Neurobiology, Northwestern University, Evanston, IL 60208.
Sabra M AbbottDepartment of Neurology, Northwestern University, Chicago, IL 60611.
Kathryn J ReidDepartment of Neurology, Northwestern University, Chicago, IL 60611.
Phyllis C ZeeDepartment of Neurobiology, Northwestern University, Evanston, IL 60208.
Ravi AlladaNSF-Simons Center for Quantitative Biology, Northwestern University, Evanston, IL 60208.

Funding

SLOW WAVE SLEEP AND TYPE 2 DIABETES RISK IN AGINGP01AG011412 · NIA · UNIVERSITY OF CHICAGO · PI ZEE, PHYLLIS C. · 1994 to 2021
$31.5M
Strengthening circadian signals to enhance cardiometabolic functionR01HL140580 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ZEE, PHYLLIS C. · 2017 to 2021
$3.4M
NHLBI NIH HHS R01 HL140580NIA NIH HHS P01 AG011412
6 · The paper itself

Abstract

Circadian clocks play a key role in regulating a vast array of biological processes, with significant implications for human health. Accurate assessment of physiological time using transcriptional biomarkers found in human blood can significantly improve diagnosis of circadian disorders and optimize the delivery time of therapeutic treatments. To be useful, such a test must be accurate, minimally burdensome to the patient, and readily generalizable to new data. A major obstacle in development of gene expression biomarker tests is the diversity of measurement platforms and the inherent variability of the data, often resulting in predictors that perform well in the original datasets but cannot be universally applied to new samples collected in other settings. Here, we introduce TimeSignature, an algorithm that robustly infers circadian time from gene expression. We demonstrate its application in data from three independent studies using distinct microarrays and further validate it against a new set of samples profiled by RNA-sequencing. Our results show that TimeSignature is more accurate and efficient than competing methods, estimating circadian time to within 2 h for the majority of samples. Importantly, we demonstrate that once trained on data from a single study, the resulting predictor can be universally applied to yield highly accurate results in new data from other studies independent of differences in study population, patient protocol, or assay platform without renormalizing the data or retraining. This feature is unique among expression-based predictors and addresses a major challenge in the development of generalizable, clinically useful tests.

Indexed as

Machine LearningBiomarkersCircadian ClocksCircadian RhythmGene ExpressionGene Expression ProfilingGenesHumansModels, StatisticalReproducibility of ResultsSleepTranscriptomeBiomarkerscircadian rhythmscross-platform predictiongene expression dynamicsmachine learning

Identifiers

PMID30201705
PMCPMC6166804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.